Lamotrigine in the treatment of SUNCT syndrome.
Short-lasting, unilateral, neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) is considered an intractable condition. The authors treated five patients with lamotrigine (125 to 200 mg daily), obtaining a complete remission in three patients and a substantial reduction (about 80%) of attack frequency in the other two. No adverse effects were noted.
D'Andrea
G
G
Headache and Comorbidity Center, Pathology Unit, Este-Monselice Hospital, Este, Italy.
Granella
F
F
Ghiotto
N
N
Nappi
G
G
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D005260:Female; D020773:Headache Disorders / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008875:Middle Aged; D014227:Triazines / Q000627:therapeutic use*
D000700:Analgesics; D014227:Triazines; D000077213:Lamotrigine